Are you Dr. Mani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 103 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
603 N Flamingo Rd
Suite #157
Pembroke Pines, FL 33028Phone+1 954-844-6898Fax+1 954-438-5191
Summary
- Dr. Aruna Mani, MD is an oncologist in Pembroke Pines, Florida. She is currently licensed to practice medicine in Florida, California, and Ohio. She is affiliated with Memorial Hospital Pembroke, Memorial Hospital Miramar, and Jackson Health System.
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2007
- Cleveland Clinic FoundationResidency, Internal Medicine, 2002 - 2005
- Northeast Ohio Medical UniversityClass of 2002
Certifications & Licensure
- CA State Medical License 2016 - 2024
- FL State Medical License 2008 - 2018
- OH State Medical License 2005 - 2016
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 37 citationsIpatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity...Nicholas C. Turner, Rebecca Dent, Joyce O'Shaughnessy, Sung-Bae Kim, Steven J. Isakoff
Breast Cancer Research and Treatment. 2021-12-03 - 40 citationsFinal results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastati...Rebecca Dent, Mafalda Oliveira, Steven J. Isakoff, Seock-Ah Im, Marc Espié
Breast Cancer Research and Treatment. 2021-07-15 - 198 citationsTrastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multi...Leisha A. Emens, Francisco J. Esteva, Mark Beresford, Cristina Saura, Michelino De Laurentiis
The Lancet. Oncology. 2020-10-01
Professional Memberships
- Member